Story perspectives

Court Hears Monsanto Case as Trump Deems Glyphosate Security Essential

5/2/2026

Summary

Monsanto Defends Glyphosate

The Court heard oral arguments on April 27, 2026 in Monsanto Co. v. Durnell.
John Durnell’s 2019 lymphoma suit earned a $1.25 million Missouri jury award in 2023, upheld in February 2025.
Monsanto says EPA’s 2009-2019 finding that glyphosate is not carcinogenic bars any added cancer warning on Roundup’s label.
President Donald Trump signed a February 2026 order labeling glyphosate essential to national security while Senator Ted Cruz introduced an April 2026 bill to block pesticide lawsuits.

Summary

Economists Warn

Economists warn that courts overturning EPA pesticide approvals could force firms to meet up to 50 state standards, slowing innovation.
Analysts estimate fragmented regulations would add billions in development costs and raise consumer prices.
Roundup’s role in U.S. crop yields means litigation could cut agricultural productivity and increase food costs.
The EPA’s ongoing review can incorporate new scientific data, offering a more predictable safety framework than unpredictable jury verdicts.
London police reported targeting terrorist ‘thugs for hire’ in a proxy-fought hybrid war, raising broader security concerns.

Summary

Senators Challenge Immunity

Senators Heinrich, Booker, Markey, Merkley and Welch co-sponsored the No Immunity for Glyphosate Act to overturn Trump’s immunity order.
Rep. Thomas Massie and Rep. Chellie Pingree urged removal of glyphosate language, noting Bayer’s $9 million lobbying spend.
Rep. Alexandria Ocasio-Cortez asked EPA Administrator Lee Zeldin for logs and emails showing Bayer executives met agency.
Bayer CEO Bill Anderson called the case “good news for U.S. farmers” and proposed a $7.25 billion settlement.

History

Historical Context

In 1991, the U.S. Environmental Protection Agency labeled glyphosate a probable human carcinogen, igniting nationwide health concerns for agricultural use. That ruling spurred litigation, culminating in a $1.25 million Missouri jury verdict against Monsanto in 2023 and $9 million Bayer lobbying expenditures. Now, President Donald Trump’s February 2026 executive order declares glyphosate vital for national security, while Senators Ted Cruz and Alexandria Ocasio-Cortez introduce bills to strip that immunity, echoing the 1991 controversy. The clash threatens fragmented state regulations, which analysts warn could add billions in compliance costs and trigger a $7.25 billion settlement proposal from Bayer CEO Bill Anderson.

1 of 4

Monsanto Defends Glyphosate

The Court heard oral arguments on April 27, 2026 in Monsanto Co. v. Durnell.
John Durnell’s 2019 lymphoma suit earned a $1.25 million Missouri jury award in 2023, upheld in February 2025.
Monsanto says EPA’s 2009-2019 finding that glyphosate is not carcinogenic bars any added cancer warning on Roundup’s label.
President Donald Trump signed a February 2026 order labeling glyphosate essential to national security while Senator Ted Cruz introduced an April 2026 bill to block pesticide lawsuits.

1 / 4